After the recent rights issue, Ascelia has SEK 75.
Redeye takes a positive stance on Teneo AI raising SEK60m from a directed share issue.
Investors House reported Q4 revenues of EUR 2.8m, 7% above our estimate.
Redeye updates on EG7 post Q4-results which were in line with our forecast.
Redeye makes positive estimate adjustments on the back of I-Tech’s record Q4 report delivering y/y g...
Redeye updates its estimates ahead of Arise’s Q4 report, which is due on Valentine’s Day (Friday 14 ...
Redeye remains positive to Bredband2 following a Q4 2024 report in line with forecast.
Strong Q4 driven by Engineered Solutions EBITA up 2% organically, but cancelled out by weaker FX Sha...
We trim '25e-'26e ARR by 1% on continued macro weakness Still awaiting a return in B2C business mome...
Minor estimate revisions Tougher order intake comps in Q4 NTM EV/EBIT around 7x What to look for in...
DT already achieved a strong year in terms of profitability, and although earnings growth may no lon...
Medclair AB (”Medclair” eller ”Bolaget”) är idag den enda aktören som erbjuder mobila lösningar för ...
EBITA SEK 240m (+2% vs. ABG, +3% vs. IR consensus) We expect cons EBITA to come up by ~1-2% Trading ...
Utvecklingen inom portföljbolagen visar på förbättring, där nu Voi uppnått ett positivt rörelseresul...
Redeye states AVTECH delivered a solid report in line with preliminary figures and beat Redeye Resea...
